patent semaglutide Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants China's weight-loss drug makers take

Shiro Glutathione injection is a naturally occurring chemical discovered in the human body as well as in all our cells, including the skin and various other organs

For pharma manufacturers, biosimilar developers, independent pharmacy operators, and plan sponsors, each of these pressures translates directly into formulary access risk, reimbursement rate volatility, and contract renegotiation exposure

The chemical structures and their classification are shown in Fig

Not only are the medications slightly different, but people are also very different, says Kershaw

If your plan says Wegovy is a nonpreferred brand drug (tier 3 or 4) , your portion of costs will be higher